For the second trading session in less than a week, Roche Holding ( RHHBY -6.02%) stock really took it on the chin Wednesday.

Roche Holding's chairman criticizes industrial subsidies as wasteful, advocating for fair competition and government ...

Positive clinical trial results for Merck & Co's experimental antiviral COVID-19 pill reverberated through the health care sector on Friday, sending the drugmaker's stock price soaring while ...

Roche's diversified portfolio and ongoing GLP-1 developments offer decent upside with limited downside. Read more about RHHBY ...

Stifel Nicolaus analyst Eric Le Berrigaud has maintained their neutral stance on RHHVF stock, giving a Hold rating ... of considerations surrounding Roche Holding AG’s recent developments ...

BofA securities has upgraded Roche to a "buy," setting a target price of CHF 340, due to a positive outlook on the company's growth. Meanwhile, Deutsche Bank (ETR:DBKGn) has downgraded the stock to ...

In a meeting of the European Association for the Study of Diabetes that day, Roche presented the results of an early-stage clinical trial of its CT-996 pill. This is the Switzerland-based company ...

Roche currently carries a Zacks Rank #2 (Buy). Intuitive Surgical ISRG is another top-ranked stock from the broader medical space, sporting a Zacks Rank #1 (Strong Buy) at present. You can see the ...